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Background: Sertoli cells play key roles in regulating spermatogenesis and testis development by providing
structural and nutritional supports. Recent studies demonstrate that Sertoli cells can be converted into functional
neural stem cells. Adult Sertoli cells have previously been considered the terminally differentiated cells with a fixed
and unmodifiable population after puberty. However, this concept has been challenged. Since the number of adult
human Sertoli cells is limited, it is essential to culture these cells for a long period and expand them to obtain
sufficient cells for their basic research and clinic applications. Nevertheless, the studies on human Sertoli cells are
restricted, because it is difficult to get access to human testis tissues.
Results: Here we isolated adult human Sertoli cells with a high purity and viability from obstructive azoospermia
patients with normal spermatogenesis. Adult human Sertoli cells were cultured with DMEM/F12 and fetal bovine
serum for 2 months, and they could be expanded with a 59,049-fold increase of cell numbers. Morphology,
phenotypic characteristics, and the signaling pathways of adult human Sertoli cells from different passages were
compared. Significantly, adult human Sertoli cells assumed similar morphological features, stable global gene
expression profiles and numerous proteins, and activation of AKT and SMAD1/5 during long-period culture.
Conclusions: This study demonstrates that adult human Sertoli cells can be cultured for a long period and expanded
with remarkable increase of cell numbers whilst maintaining their primary morphology, phenotype and signaling
pathways. This study could provide adequate human Sertoli cells for reproductive and regenerative medicine.
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AKT and SMAD1/5 signaling pathwaysIntroduction
Spermatogenesis is an elaborate process by which
spermatogonial stem cells (SSCs) self-renew and differ-
entiate into mature spermatozoa in mammalian testis.
The microenvironment or niche is required for normal
spermatogenesis. The niche comprises mainly Sertoli
cells, cytokines and growth factors produced by Sertoli
cells, peritubular myoid cells and blood vessels. As the* Correspondence: zupinghe@sjtu.edu.cn
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unless otherwise stated.key component of the niche of mammalian testis, Sertoli
cells play essential roles in controlling spermatogenesis [1].
Sertoli cells are also called “mother cells” or “nurse cells”
for male germ cells, reflecting a unique role for these cells
in male germ cell development and maturation. Sertoli cells
stretch from the basement membrane to the lumen within
the seminiferous tubules, and they are in intimate contact
with male germ cells and provide structural, immuno-
logical, and nutritional support to these cells [1].
Studies on Sertoli cells are of usual significance due to
the following three aspects. First of all, Sertoli cells are a
major orchestrator of the testis during sex differentiation
and male germ cell development, as evidenced by the
fact that they express Sry [2] and initiate the cascades of
genes which regulate the formation of seminiferous cord
and sex-specific vascular development [3-5]. Sertoli cellsis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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trol the self-renewal and differentiation of SSCs, meiosis
of spermatocytes, and transformation of round sperma-
tids to spermatozoa [6]. For instance, stem cell factor
(SCF, also known as KIT ligand and steel factor) and
bone morphogenic protein 4 (BMP4) secreted by Sertoli
cells have been shown to induce the differentiation of
SSCs [7-10]. Glial cell line-derived neurotrophic factor
(GDNF), another critical growth factor produced by
Sertoli cells, promotes the survival and self-renewal of
mouse SSCs [11-16], since mice overexpressing GDNF
have an accumulation of undifferentiated spermatogonia
[13,17]. We have recently revealed distinct expression of
SCF, BMP4, and GDNF in human Sertoli cells between
non-obstructive azoospermia (NOA) patients with im-
paired spermatogenesis and obstructive azoospermia
(OA) patients with normal spermatogenesis [18], sug-
gesting that there might exist an association of these
factors secreted by Sertoli cells and male infertility.
Sertoli cells, serving as feeder cells, have been applied in
the expansion and differentiation of SSCs in vitro
[19-22]. Secondly, Sertoli cells are an essential compo-
nent of testicular blood-testis-barrier (BTB) that is
composed of Sertoli cell tight junctions, the body of the
Sertoli cell, and peritubular cells [23-25]. The BTB has
been regarded as the main defense against the invading
immune cells which may attack immunogenic germ
cells. Since most of male germ cells develop after the
immune system is fully functional, they are autoimmu-
nogenic [26]. Sertoli cells are considered as immunopri-
vileged cells, and they have been regarded as a major
component of the defense against the immune system
by expressing several immuno-regulatory factors, e.g.,
Fas ligand (FasL), transforming growth factor B1 (TGFB1)
and clusterin [27-32]. Moreover, immune modulation by
Sertoli cells is not restricted to the testes because Sertoli
cells also survive when transplanted to ectopic sites
[33-42]. Thirdly, Sertoli cells have been reprogrammed to
generating the induced pluripotent stem (iPS) cells [43],
and notably, Sertoli cells can be directly converted into
morphologic, phenotypic, and functional neural stem cells
[44]. Sertoli cells have been engineered to secrete the
necessary proteins capable of restoring normal cell and
metabolic function [45], indicating extreme promise of
Sertoli cells to be exploited in cell-based therapy. Thus,
Sertoli cells may have important implications for disease
modeling and regenerative medicine.
Adult Sertoli cells have previously been considered the
terminally differentiated cells with a fixed and unmodifiable
population after puberty. Nevertheless, this concept has
recently been challenged [46], because Sertoli cells from
adult hamsters can regain proliferative ability after being
administration of follicle-stimulating hormone and they
have the proliferation potential [47]. Since the number ofadult human Sertoli cells is limited, it is essential to cul-
ture these cells for a long period and expand them for
their use in basic research and clinic applications. How-
ever, the studies of human Sertoli cells are restricted, due
to the limited access to human testis tissues. In this study,
we first isolated and purified adult human Sertoli cells
from OA patients with normal spermatogenesis. We iden-
tified adult human Sertoli cells using numerous markers
for Sertoli cells and then cultivated them for a long period,
with a remarkable increase of cell numbers. We further
compared morphology, phenotypic characteristics, and
AKT and SMAD1/5 activation of adult human Sertoli cells
at different passages. Significantly, we found that adult
human Sertoli cells assumed similar morphological fea-
tures and they had stable global gene expression profiling
and a number of proteins, and AKT and SMAD1/5 activa-
tion during long-term cultivation. Considered together, we
have demonstrated that adult human Sertoli cells can be
cultured for long term and expanded while maintaining
their primary morphology, phenotype, and signaling path-
way activation, which underscores their promising applica-
tions in both reproductive and regenerative medicine.
Materials and methods
Procurement of testicular biopsies from OA patients with
normal spermatogenesis
Testicular biopsies were obtained from 50 OA patients (age
ranging from 22 to 35 years old) who underwent microdis-
section and testicular sperm extraction (MD-TEST) at Ren
Ji Hospital affiliated to Shanghai Jiao Tong University School
of Medicine. All patients with OA were caused by inflam-
mation and vasoligation but not by congenital absence of
the vas deferens (CBAVD) or other diseases including
cancer. This study was approved by the Institutional Ethical
Review Committee of Ren Ji Hospital (license number of
ethics statement: 2012–01), Shanghai Jiao Tong University
School of Medicine, and the consents for testicular biopsies
were obtained from the donors for research only.
Histological examination
Testicular biopsies from OA patients were fixed in
Bouin’s fixative overnight, embedded in paraffin and sec-
tioned at 5 μm thickness. The sections were stained with
hematoxylin and eosin (H&E) and observed to check
spermatogenesis status under a microscope.
Isolation and identification of human Sertoli cells from
OA patients
Testicular biopsies obtained from OA patients were washed
three times aseptically in Dulbecco modified Eagle medium
(DMEM) (Gibco) containing antibiotic with penicillin and
streptomycin (Gibco). Human seminiferous tubules were
isolated from testis biopsies by the first enzymatic digestion
comprising 2 mg/ml collagenase IV (Gibco) and 1 μg/μl
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to the procedure as described previously [48]. Sertoli
cells and human male germ cells were obtained from
seminiferous tubules using a second enzymatic diges-
tion with 4 mg/ml collagenase IV, 2.5 mg/ml hyaluroni-
dase (Sigma), 2 mg/ml trypsin (Sigma) and 1 μg/μl
DNase I and followed by differential plating according
to the procedure as we previously described [48]. For
differential plating, cell suspension was seeded into cul-
ture plates in DMEM/F-12 supplemented with 10% fetal
bovine serum (FBS) (Gibco) and incubated at 34°C in 5%
CO2 overnight. After incubation, the medium containing
male germ cells were removed, and Sertoli cells attached
to culture plates. The viability of freshly isolated human
Sertoli cells was assessed by exclusion of trypan blue
staining. Human Sertoli cells were identified by immu-
nostaining with antibodies against GATA4, WT1,
vimentin (VIM), GDNF, BMP4, SCF, and PCNA (prolif-
erating cell nuclear antigen) as described below.
Long-term culture of human Sertoli cells from OA patients
Human Sertoli cells were cultured with DMEM/F12 sup-
plemented 10% heat-inactivated FBS (Gibco), 2 mM L-
glutamine (Invitrogen), and 100 unit/ml penicillin and
streptomycin (Gibco). The cells were passaged when cell
confluence reached 80%, and they were maintained at
34°C in a humidified 5% CO2 incubator and cultivated
for 2 months. The proliferation potentials of human Ser-
toli cells at different passages were detected by cell
counting using the cytometer.
RNA extraction and reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA was extracted from freshly isolated and passaged
human Sertoli cells using the Trizol reagent (Invitrogen),
and the quality and concentrations of total RNA were mea-
sured by Nanodrop. Reverse transcription (RT) was per-
formed using the First Strand cDNA Synthesis Kit (Thermo
Scientific), and PCR of the cDNA was carried out according
to the protocol as described previously [49]. The primers of
the chosen genes, including GATA1 (GATA binding protein
1), GATA4 (GATA binding protein 4), WT1 (Wilms tumor
1), GDNF, BMP4, SCF, FGF2 (fibroblast growth factor 2),
EGF (epithelial growth factor), FSHR (follicle-stimulating
hormone receptor), AR (androgen receptor), ABP (androgen
binding protein, also known as sex hormone-binding globu-
lin, SHBG), and ACTB (actin beta), were designed and listed
in Table 1. The PCR reaction started at 94°C for 2 min and
was performed as follows: denaturation at 94°C for 30 sec,
annealing at 55-60°C for 45 sec as listed in Table 1, and
elongation at 72°C for 45 sec. After 35 cycles, the samples
were incubated for an additional 5 min at 72°C. PCR
products were separated by electrophoresis on 2%
agarose gel and visualized with ethidium bromide.Images were recorded and band intensities were analyzed
using chemiluminescence (Chemi-Doc XRS, Bio-Rad)
[18]. RNA without reverse transcriptase enzyme but
with PCR of ACTB primers served as negative controls.
The integrated density values (IDV) of target gene products
were quantified relatively by comparing with the expression
of housekeeper gene ACTB.Immunocytochemistry
For immunocytochemical staining, the freshly isolated
and cultured human Sertoli cells as well as human male
germ cells were fixed with 4% paraformaldehyde (PFA)
for 30 min, washed three times with cold phosphate-
buffered saline (PBS) and permeabilized in 0.4% triton-X
100 (Sigma) for 5 min. After washing with PBS, the cells
were blocked in 2% BSA for 30 min and followed by in-
cubation with primary antibodies, including anti-GATA4
(Santa Cruz), WT1 (Santa Cruz), GDNF (Santa Cruz),
anti-SCF (Sigma), anti-BMP4 (Abcam), anti- VIM (Santa
Cruz), anti-PCNA (Sigma), anti-SMA (smooth muscle
alpha actin, Abcam) and CYP11A1 (cholesterol side-
chain cleavage enzyme, Abcam) at a dilution with 1:200
overnight at 4°C. Isotype IgGs for the first antibody were
used as the negative controls. After extensive washes
with PBS for 30 min, the cells were incubated with the
secondary antibody IgG (Sigma) conjugated with fluores-
cein isothiocyanate (FITC) or rhodamine at a 1:200 dilution
for 1 hour at room temperature. DAPI (4,6-diamidino-2-
phenylindole) was used to label the nuclei, and the cells
were observed for epifluorescence under a fluorescence
microscope (Leica).Microarray analysis
Total RNA was obtained from human Sertoli cells at
passage one (P1), passage five (P5) and passage ten (P10)
using Trizol reagent (Invitrogen). The concentrations
and purity of total RNA were evaluated by measuring
the 260/280 nm ratio, and the integrity of total RNA was
assessed by 1.0% denaturing agarose gel electrophoresis.
Five micrograms of total RNA were reverse-transcribed
into single strand cDNA that was subsequently converted
to double strand cDNA. The purified double strand
cDNA served as a template to synthesize biotin-labeled
cRNA using the GeneChip2 WT Terminal Labeling Kit
(Affymetrix), and the biotin-labeled cRNA was puri-
fied using the GeneChip Sample Cleanup Module kit
(Affymetrix) and fragmented to 35–200 bases. The
fragmented cRNA was hybridized to Affymetrix Gene-
Chip Human Gene 1.0 ST Arrays and stained using
the GeneChip2 Hybridization, Wash, and Stain Kit
(Affymetrix). The arrays were scanned with a Gene-
Chip2 Scanner 3000 7G (Affymetrix), and raw data
were analyzed using the GeneSpringGX software.
Table 1 The sequences of gene primers used for RT-PCR
Gene Primer sequence Product size (bp) Tm(°C)
WT1 Forward TGACTCTCCACTCCTCCTCAC 170 60
Reverse ACCAACTCTTCCAGGCACAC
GATA4 Forward GCCTCCTCTGCCTGGTAAT 210 60
Reverse CAGTCCCATCAGCGTGTAAA
GATA1 Forward GAAACCGCAAGGCATCTG 140 60
Reverse CCCAGCCACCACCATAAAG
GDNF Forward TGAAACCAAGGAGGAACT 180 58
Reverse CACTCACCAGCCTTCTATT
BMP4 Forward TTTGTTCAAGATTGGCTGTC 324 60
Reverse AGATCCCGCATGTAGTCC
SCF Forward GTCATTGTTGGATAAGCGAGAT 457 60
Reverse ATGGCTGCCCAGTGTAGG
FGF2 Forward TCCTTTCTCCCTCGTTTCTTC 195 55
Reverse GATGTTTCCCTCCAATGTTTC
EGF Forward CTGATATAGATGAATGTGAGATGGG 190 55
Reverse GTGGAGTAGAGTCAAGACAG
FSHR Forward TCTGCTGGTTCTGTTTCA 215 58
Reverse CATTCCTTGGATGGGTGT
AR Forward CCTTCACCAATGTCAACTCC 197 60
Reverse CCACTGGAATAATGCTGAAGAG
ABP Forward GGCTTTACCAGGAGAAGAC 150 60
Reverse CATGGCTTCTGTTCAGGG
ACTB Forward CGCACCACTGGCATTGTCAT 253 55
Reverse TTCTCCTTGATGTCACGCAC
Figure 1 Morphology of the testes from OA patients and the
isolation of human Sertoli cells from patients with OA. (A) H&E
staining revealed the morphology of testicular tissues from OA patients.
(B) Seminiferous tubules were obtained after the first enzymatic digestion
with collagenase IV and DNase I. (C) The mixture of male germ cells and
Sertoli cells was isolated from seminiferous tubules using the second
enzymatic digestion. (D) Sertoli cells remained in the culture plates
after differential plating with the removal of male germ cells. Scale
bars in A-C = 100 μm; scale bar in D = 50 μm.
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The cultured human Sertoli cells at different passages
were lysed with RIPA buffer (Santa Cruz) for 30 min on
ice. After 30 min lysis on ice, cell lysates were cleared by
centrifugation at 12,000 g, and the concentration of pro-
tein was measured by BCA kit (Dingguo Company,
China). Thirty micrograms of cell lysate from each sam-
ple were used for SDS-PAGE (Bio-Rad Laboratories,
Richmond, CA), and Western blots were performed
according to the protocol as described previously [11].
The chosen antibodies included anti-SCF (Sigma), anti-
GDNF (Santa Cruz), anti-BMP4 (Abcam), anti-PCNA
(Santa Cruz), anti-phos-AKT (Cell Signaling), and anti-
phos-SMAD1/5 (Cell Signaling). After extensive washes
with PBS, the blots were detected by chemiluminescence
(Chemi-Doc XRS, Bio-Rad), and the integrated density
values (IDV) was calculated by comparing the signals of
target proteins with that of housekeeper ACTB (Santa
Cruz).
Statistical analysis
All the values were presented as mean ± SEM, and statis-
tically significant differences (p < 0.05) between different
Figure 2 Gene and protein characterization of the freshly
isolated human Sertoli cells. (A) RT-PCR showed the expression of
numerous genes, including WT1, GATA4, GATA1, GDNF, BMP4, SCF,
FGF2, EGF, FHSR, AR and ABP. ACTB was used as a loading control,
and RNA without reverse transcriptase enzyme but with PCR of ACTB
primers was used as a negative control (NC). (B-I) Immunofluorescence
revealed the expression of WT1 (B), GDNF (C), SCF (D), BMP4 (E),
VIM (F), PCNA and GATA4 (G), SMA (H), and CYP11A1 (I) in isolated
human Sertoli cells. Scale bars in B, C, D, F, H =50 μm; scale bars in
E, G, I =20 μm.
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the analysis of variance (ANOVA) and a 2-tailed t-test.
The band intensities of Western blots were quantified by
ImageJ software (NIH).
Results
Isolation of human Sertoli cells from OA patients
Histological analyses of testicular tissues revealed that
50 OA patients we used in this study had normal sperm-
atogenesis (Figure 1A). Human Sertoli cells were isolated
from OA patients by a two-step enzymatic digestion and
followed by differential plating as previously described
[48]. In brief, human seminiferous tubules (Figure 1B)
were obtained from the testis tissues using the first
enzymatic digestion and extensive washes using PBS to
remove potential contamination of myoid cells. Male germ
cells and Sertoli cells (Figure 1C) were obtained using a
second enzymatic digestion and they were cultured with
DMEM/F12 and 10% FBS overnight for differential plat-
ing. Human Sertoli cells (Figure 1D) attached to the plates
for the subsequent culture. The viability of freshly isolated
cells was over 98%, as assayed by trypan blue exclusion
(data not shown).
Identification of human Sertoli cells from OA patients
The freshly isolated human Sertoli cells were identified
using a number of markers of Sertoli cells. RT-PCR
showed that the transcripts of WT1, GATA4, GATA1,
GDNF, BMP4, SCF, FGF2, EGF, FHSR, AR and ABP were
expressed in the isolated Sertoli cells (Figure 2A). Im-
munocytochemistry further revealed that primary human
Sertoli cells were positive for WT1 (Figure 2B), GDNF
(Figure 2C), SCF (Figure 2D), BMP4 (Figure 2E), VIM
(Figure 2F), and PCNA and GATA4 (Figure 2G). No
positive staining was seen when primary antibodies were
replaced with isotype rabbit or goat IgGs (Additional
file 1: Figure S1) or in human male germ cells with these
antibodies (Additional file 2: Figure S2), confirming the
specific expression of these proteins in freshly isolated
human Sertoli cells. The purity of isolated Sertoli cells was
more than 95% as showed by our immunostaining results
that less than 5% of the cells were positive for antibodies
against SMA (Figure 2H) or CYP11A1 (Figure 2I),
markers for myoid cells and Leydig cells, respectively. To
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PCNA expression was measured and almost of the cells
were observed to be positive for both PCNA and GATA4
(Figure 2G), reflecting that human Sertoli cells have a high
level of proliferative potential.
Long-term culture of human Sertoli cells
When human Sertoli cells reached 80% of confluence,
they were passaged by the ratio 1:3. Adult human Ser-
toli cells could be passaged every 4 to 5 days until
2 months with 10 passages. We compared the morpho-
logical features of human Sertoli cells at passage one
(P1), passage five (P5) and passage ten (P10). Under the
phrase-contrast microscope, human Sertoli cells at P1,
P5 and P10 assumed similar morphology, as evidenced
by the observations that they had a large cell body, a
branching cytoplasm, and irregular nuclei (Figure 3A-
C). Cell proliferation assay showed that adult human
Sertoli cells could be expanded with a remarkable
increase of cell number by 59,049 folds after culture for
10 passages (Figure 3D), which further suggests that
human Sertoli cells possess a significant proliferation
ability.
Global gene expression profiles of human Sertoli cells at
different passages
We next compared global gene expression profiling of
human Sertoli cells at P1, P5 and P10 using microarray
analysis. To this end, total RNA was extracted from hu-
man Sertoli cells at different passages, and gel imaging
and electropherograms by Agilent bioanalyzer assaysFigure 3 Morphology and proliferation assay of human Sertoli cells in
logical characteristics of human Sertoli cells after culture for P1 (A), P5 (B),
showed the proliferative ability of human Sertoli cells when cultured for 2displayed that RNA was of great quality (Additional file
3: Figure S3A-E). Microarray analysis revealed that to-
tally 31,743 genes and the expressed sequence tags
(EST) were detected in human Sertoli cells (Figure 4A-
C). There were 597 (1.88%), 663 (2.09%), and 177
(0.56%) differentially expressed genes (up-regulated or
down-regulated with 2.0 folds or more) in Sertoli cells at
P5/P1 (Figure 4A, Table 2), P10/P1 (Figure 4B, Table 2),
and P10/P5 (Figure 4C, Table 2), respectively. Mean-
while, a number of important genes for Sertoli cells, in-
cluding WT1, GATA4, GATA1, GDNF, BMP4, KITLG
(also called SCF), FGF2, EGF, FSHR, AR and ABP, were
stably expressed in human Sertoli cells after culture for
P1, P5 and P10, since their expression was changed with
less than 2.0 folds (Table 3).
To confirm the results of microarray analysis, RT-PCR
was performed to check the expression of WT1, GATA4,
GATA1, GDNF, BMP4, KITLG (SCF), FGF2, EGF, FSHR,
AR, and ABP. Notably, there was no significantly statis-
tical difference between the expression of these genes
mentioned above in human Sertoli cells at P1, P5, P10
(Figure 5A and B), which were consistent with the data
of our mRNA microarray.
Stable expression of numerous proteins in human Sertoli
cells at P1, P5, and P10
Due to the important function of GDNF, SCF and BMP4
in the regulation of spermatogenesis, we further exam-
ined the protein expression of these growth factors in
human Sertoli cells at P1, P5, and P10. Western blots re-
vealed that GDNF, SCF and BMP4 proteins were stablyculture. (A-C) Phase-contrast microscope displayed the morpho-
and P10 (C). Scale bars in A-C = 50 μm. (D) Cell proliferation assay
months.
Figure 4 Microarray analysis revealed global gene expression
patterns in human Sertoli cells at different passages. (A-C)
Scatter plots displayed the large scale gene expression profiles in
human Sertoli cells at P5/P1 (A), P10/P1 (B), and P10/P5 (C). Each
dot presented one gene or the expressed sequence tags (EST).
Table 2 The number of the differentially expressed genes
in human Sertoli cells at P5/P1, P10/P1 and P10/P5 by
microarray analysis
Group Up-regulated genes Down-regulated genes Percentage
P5/P1 307 290 1.88%
P10/P1 324 339 2.09%
P10/P5 106 71 0.56%
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tured for 1, 5, and 10 passages (Figure 6A-D).
Immunofluorescence further showed the expression of
WT1, GDNF, SCF, BMP4, VIM, PCNA and GATA4 was
retained at higher levels in human Sertoli cells after cul-
ture for 5 passages (Additional file 4: Figure S4) and 10
passages (Additional file 5: Figure S5), which was com-
parable to the expression of these proteins in freshly iso-
lated human Sertoli cells (Figure 2). In contrast, SMA
and CYP11A1 were detectable in very few human Sertoli
cells after culture for 5 passages (Additional file 4: Figure
S4) and 10 passages (Additional file 5: Figure S5).
Expression of PCNA, phos-AKT and phos-SMAD1/5 in hu-
man Sertoli cells at different passages
We also compared the proliferation potential and signal-
ing pathways of human Sertoli cells after culture for 1, 5,
and 10 passages. Western blots showed that there was
no difference in the expression of PCNA in human Ser-
toli cells at P1, P5, and P10 (Figure 7), and phos-AKT
and phos-SMAD1/5 were expressed at similar levels in
human Sertoli cells at P1, P5, and P10 (Figure 7). These
data suggest that the activation of AKT and SMAD1/5
signaling pathways was maintained in human Sertoli
cells during the long-period culture.
Discussion
Sertoli cells are essential for spermatogenesis and testis
development. The unique and appropriate regulation of
the niche is required for normal spermatogenesis, and
the integrity of niche relies on Sertoli cells [50]. Sertoli
cells keep close contact with all male germ cells, includ-
ing spermatogonia, spermatocytes, round spermatids
and elongated spermatids [51], and they provide struc-
tural, immunological and nutritional support to each
step of male germ cell development [52]. Sertoli cells
could secret a number of growth factors and cytokines
that are pivotal for spermatogenesis [50,53]. Therefore, it
is of great significance to understand the biology of Ser-
toli cells, which could have great impact on male
reproduction and on cell-based therapy in regenerative
medicine. However, there are very few studies on human
Sertoli cells because it is rather difficult to obtain human
testis tissues. In this study, we have isolated and cultured
adult human Sertoli cells for a long period with a
Table 3 The expression of numerous genes in human Sertoli cells at P5/P1, P10/P1 and P10/P5 by microarray analysis
Gene
symbol
Description Normalized Intensity log2 (Ratio)
P1 P10 P5 P10/P1 P5/P1 P10/P5
WT1 Wilms tumor 1 219.234818 161.693756 198.794189 −0.774764 −0.36631 −0.420787
GATA4 GATA binding protein 4 3865.29419 4788.86475 5275.979 0.295279 0.40343 −0.128533
GATA1 GATA binding protein 1 1037.77979 1873.12756 1690.21729 0.715539 0.529079 0.104663
KITLG KIT ligand 170.060654 236.24087 244.52618 0.13905 0.297491 −0.169023
GDNF glial cell derived neurotrophic factor 235.626205 198.442337 173.594925 −0.584025 −0.668577 0.071242
BMP4 bone morphogenetic protein 4 13598.7051 17179.4355 19054.377 0.351068 0.44625 −0.114685
FGF2 fibroblast growth factor 2 (basic) 10512.002 10258.1035 10363.4307 −0.045128 −0.060692 −0.008951
EGF epidermal growth factor 210.014664 313.937866 237.059738 0.238724 −0.052155 0.285537
FSHR follicle stimulating hormone receptor 14.342464 38.848499 21.46604 1.437565932 0.5817631 0.8558028
AR androgen receptor 2127.80713 1999.12268 2071.93945 −0.160308 −0.174322 −0.08023
SHBG/ABP sex hormone-binding globulin 389.295471 413.684021 454.52005 −0.254276 −0.036372 −0.231509
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ible for the wide application of Sertoli cells in both basic
research and clinical use.
We obtained the biopsies of testis tissue from OA pa-
tients who underwent MD-TESE. The OA patients had
integral and normal spermatogenesis as shown by our
histological analyses of testicular tissues. Using the two-
step enzymatic digestion and followed by differential
plating, Sertoli cells were isolated with a high viability
from OA patients. We found that numerous genes, in-
cluding WT1, GATA1, GATA4, GDNF, BMP4, SCF,
FGF2, EGF, FHSR, AR and ABP, were expressed in
freshly isolated human Sertoli cells. The transcription
factor WT1 is expressed in Sertoli cells [54] and it is a
marker of Sertoli cells [55]. WT1 is critical for mouse
spermatogenesis via the regulation of Sertoli cell polarity
and it is associated with NOA [56], suggesting that WT1
mutation is one of the genetic causes of NOA in
humans. Gata factors are important transcriptional regu-
lators of Sertoli cell-specific gene expression [57,58], and
Sertoli cells are known to express GATA 1, 4 and 6
[59,60]. Mutation in the GATA1 has been reported in
cryptorchidism [61], implicating GATA1 deficiency is as-
sociated male reproductive disorder. GATA4 is
expressed in Sertoli cells [62], and Gata4 conditionally
knockout mice have testicular atrophy and loss of fertil-
ity with Sertoli cell vacuolation [63], suggesting that
GATA4 is a key transcriptional regulator of Sertoli cells
and spermatogenesis. GDNF is secreted by Sertoli cells
[13,64]. Overexpression of GDNF stimulates mouse self-
renewal of SSCs and GDNF-null allele results in Sertoli
cell-only seminiferous tubules [13]. A large number of
studies have showed that GDNF is essential for the self-
renewal of mouse SSCs [1,15,65]. We have demonstrated
that GDNF promotes mouse SSC proliferation by acting
on c-Fos transcription through the Ras/Erk 1/2 pathway
[11]. BMP4 is synthesized by Sertoli cells [10], and itexerts both mitogenic and differentiation effects [10].
SCF can induce mouse spermatogonia to differentiate
into meiotic spermatocytes and eventually haploid round
spermatids [8]. SCF is present in human Sertoli cells and
its transcript is lower in testicular biopsies of patients
with spermatogenic failure and in Sertoli cells of NOA
patients [18,66,67]. Therefore, SCF may contribute to
the deficiency in sterility. It has been demonstrated that
SCF is essential for inducing the differentiation of SSCs
[68]. FGF2 is secreted by Sertoli cells, Leydig cells and
germ cells [69], and it is required for SSC self-renewal
[48,70-74]. Moreover, FGF2 can strongly stimulate
GDNF transcript to facilitate the division of SSCs
[75,76]. EGF is crucial for spermatogenesis [75] and it
stimulates the expansion of SSCs in vitro [48,72-74]. It
has been shown that submandibular gland ablation leads
to decreased circulating EGF and infertility, which could
be reversed by EGF in mice [77], highlighting an import-
ant role of EGF in spermatogenesis. In addition, Sertoli
cells exclusively possess receptor for FSH and they are
the major targets of the ultimate hormonal signals to
regulate spermatogenesis [78]. A number of independent
studies have identified FSH-inducible genes (e.g., FSHR,
ABP, GDNF, and SCF) in Sertoli cells that have direct ef-
fects in supporting spermatogenesis. It has recently been
reported that at least 300 genes are regulated by FSH in
Sertoli cells [79,80], reflecting a potential role of FSH/
FSHR in controlling the fate of Sertoli cells. ABP is a tes-
ticular glycoprotein which binds androgens with high af-
finity and transports them to the epididymis [81-83].
ABP has been implicated in regulating androgen activity
in the testis [84]. It is well established that androgen is
essential for the integrity of spermatogenesis [85,86],
and the biological function is mediated by AR present in
Sertoli cells [78,87]. Nuclear immunoexpression of AR is
a feature of mature Sertoli cells [55], and ablation of an-
drogen signaling in Ar knock-out or in Sertoli cell-
Figure 5 (See legend on next page.)
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Figure 5 The expression of WT1, GATA4, GATA1, GDNF, BMP4, KITLG, FGF2, EGF, FSHR, AR and ABP in human Sertoli cells after culture
for P1, P5 and P10. (A, B) RT-PCR showed the transcripts of WT1, GATA4, GATA1, GDNF, BMP4, KITLG, FGF2, EGF, FSHR, AR and ABP in human Sertoli
cells at P1, P5 and P10. ACTB was used as a loading control, and RNA without reverse transcriptase enzyme but with PCR of ACTB served as a
negative control (NC). There was no significant difference (P >0.05) in the gene expression levels of WT1, GATA4, GATA1, GDNF, BMP4, KITLG, FGF2,
EGF, FSHR, AR and ABP in human Sertoli cells after culture for P1, P5 and P10.
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[85,88-90], suggesting that AR is essential for the main-
tenance of spermatogenesis. Our results showed that the
above genes and proteins were present in the freshly iso-
lated cells, implicating that these cells were human Ser-
toli cells in phenotypes. The purity of freshly isolated
Sertoli cells was more than 95%, since our immunocyto-
chemistry revealed that over 95% of these cells were
positive for WT1, GATA4, GDNF, BMP4, SCF and VIM,
hallmarks for Sertoli cells, but not for SMA or
CYP11A1, markers for myoid and Leydig cells. Human
Sertoli cells had typical morphology which was well
maintained until 2 months of culture.
Adult Sertoli cells have previously been considered the
terminally differentiated cells with a fixed and unmodifi-
able population after puberty [91-94]; however, there is
evidence suggesting that Sertoli cells are not terminally
differentiated and quiescent [46,47]. It has been shown
that mouse and human adult Sertoli cells can be culti-
vated with 5% fetal calf serum (FCS) for 20 days with a
proliferation ability [95]. Here we found that adult hu-
man Sertoli cells can be expanded and cultured for more
than 2 months with a significant increase by 59,049-fold
of cell numbers when they were 10% FBS, reflecting that
10% FBS seems to be better than 5% FCS for the pro-
liferation of adult Sertoli cells. Almost all the cultured
human Sertoli cells were positive of PCNA, a marker for
proliferating cells [96], reflecting a strong the propagationFigure 6 Protein expression of GDNF, SCF and BMP4 in human Sertol
expression of GDNF, SCF and BMP4 in human Sertoli cells at P1, P5 and P1ability of adult human Sertoli cells. To probe the effect of
long-term culture on the global gene expression profiles,
microarray analysis was performed in human Sertoli cells
at different passages. Significantly, we revealed that 98.1%,
97.9, and 99.4% of genes maintained stable expression in
human Sertoli cells at P5/P1, P10/P1, P10/P5, respectively.
Owing to the unique and essential roles of human Sertoli
cells in regulating the self-renewal and differentiation of
SSCs, Sertoli cells have been exploited as feeder to culture
SSCs and induce the differentiation of SSCs and other
types of stem cells. The stable expression of genomic
genes guarantees proper function of Sertoli cells as feeder
cells and the application in other related studies. Mean-
while, numerous genes, including WT1, GATA4, GATA1,
GDNF, BMP4, SCF, FGF2, EGF, FHSR, AR and ABP, essen-
tial factors produced by Sertoli cells, were stably expressed
during the long term culture of Sertoli cells, suggesting
that our culture system has little effect on the expression
profile and biological functions of human Sertoli cells.
The stability of these genes expression profile was con-
firmed by RT-PCR. We also ascertained the stable protein
expression of certain critical growth factors, namely
GDNF, SCF and BMP4 in Sertoli cells at P1, P5 and P10.
Previously we found that the expression of GDNF, SCF
and BMP4 was lower in Sertoli cells from NOA patients
compared with OA patients [18], which implies that
GDNF, SCF and BMP4 secreted by human Sertoli cells are
essential for normal human spermatogenesis. Notably, wei cells at different passages. (A-D) Western blots showed the
0. ACTB was used as the control of loading proteins.
Figure 7 Expression of PCNA, phos-AKT and phos-SMAD1/5 in
human Sertoli cells after culture for 2 months. Western blots
displayed the expression of PCNA, phos-AKT, and phos-SMAD1/5 in
human Sertoli cells at P1, P5, P10. ACTB served as the control of
loading proteins.
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proliferation and activation of AKT and SMAD1/5 during
long-term culture.
In summary, we have demonstrated that adult human
Sertoli cells can be cultured for a long term and ex-
panded with a significant increase of cell numbers, while
maintaining their primary morphology, stable global
gene expression patterns and a number of proteins, and
acting signaling pathways. This study underscores that it
is reliable and feasible that cultured human Sertoli cells
can be exploited in better understanding testicular dys-
genesis syndrome, developing novel treatment for male
reproductive disorders, and regenerative medicine.
Additional files
Additional file 1: Figure S1. Negative controls for immunocytochemistry.
(A) Primary antibody was replaced by goat serum IgG. (B) Primary antibody
was replaced by rabbit serum IgG. Scale bars in A-B = 20 μm.
Additional file 2: Figure S2. Negative controls for immunocytochemistry.
(A-F) Immunofluorescence revealed the expression of WT1(A), GDNF(B),
BMP4(D), SCF(E), and VIM (E) in human male germ cells. Scale bars in
B-H =10 μm.
Additional file 3: Figure S3. The quality evaluation of RNA used for
microarray analysis. (A) Agarose gel electrophoresis showed the integrity
of total RNA used for microarray analysis. (B-E) Electropherogram by
Agilent bioanalyzer displayed total RNA of human Sertoli cells at P1 (B),
P5 (C) and P10 (D), and RNA ladder (E).
Additional file 4: Figure S4. Expression of a number of proteins after
culture for 5 passages. Immunofluorescence showed the expression of
WT1 (A), GDNF (B), SCF (C), BMP4 (D), VIM (E), PCNA and GATA4 (F), SMA
(G), and CYP11A1 (H) in human Sertoli cells at passage 5. Scale bars in A,
B, C, E,G =50 μm; scale bars in D, F, H =20 μm.
Additional file 5: Figure S5. Expression of a number of proteins after
culture for 10 passages. Immunofluorescence revealed the expression of
WT1 (A), GDNF (B), SCF (C), BMP4 (D), VIM (E), PCNA and GATA4 (F), SMA
(G), and CYP11A1 (H) in human Sertoli cells at passage 10. Scale bars in A,
B, C, E, F, G, H = 50 μm; scale bar in D =20 μm.
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